Hoffman Robert
- SEC CIK
- 0001166288
No open-market purchases or sales filed in the past year.
Current role at each company
- CIK 0001434868Directoras of Jul 13, 2026
- FBLG FibroBiologics, Inc.Directoras of Jun 23, 2026
- CYDY CytoDyn Inc.Chief Financial Officeras of Mar 24, 2026
- HURA TuHURA Biosciences, Inc.Directoras of Feb 17, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Hoffman Robert as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
HURA TuHURA Biosciences, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 17, 2022 (view filing)4:00 PM ET | Feb 15 | 2 days | Hoffman RobertPresident and CEO | PPurchase | +55.0K | $0.469 | +$25.8K | New position55.0K after |